Arab American Cancer Research

Distribution and Determinants of Cancer Risk, Survivorship and Outcomes in Middle Eastern/Arab Americans

Middle Eastern/Arab Americans represent a large, heterogeneous and quickly growing population in the U.S. Health statistics for this group are difficult to find because Arab is not a recognized category for race/ethnicity by the U.S. Census. Program members have developed and validated a naming algorithm to enhance research in a population that makes up a large portion of our catchment area. This algorithm has a positive predictive value of 91% and a negative predictive value of 100%. Using this approach in SEER data in metropolitan Detroit, California and New Jersey, we find that Arab American men and women had similar incidence rates across the three regions and rates were comparable to non-Hispanic, non-Arab whites. Among women, however, rates of thyroid were elevated; among men, rates of bladder cancer we elevated. Arab American men also had lower overall rates of cancer and rates of prostate and lung cancer than African Americans, but higher incidence than Hispanics. To evaluate the excess rate of thyroid cancer among Arab American women, program members compared risk factors to non-Hispanic white women with this disease. Arab American women had significantly higher exposures to dental x-rays and medical radiation than non-Hispanic white women.

  • Lead Researcher: Dr. Schwartz

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now